327 related articles for article (PubMed ID: 25026863)
1. [HIV infection and AIDS from the health policy viewpoint. Savings and therapy superiority maintained - a contradiction in HIV therapy?].
MMW Fortschr Med; 2014 Jun; 156 Suppl 1():62-3. PubMed ID: 25026863
[No Abstract] [Full Text] [Related]
2. [Declining costs].
Neumaier J
MMW Fortschr Med; 2016 Jun; 158 Suppl 1():58. PubMed ID: 27259908
[No Abstract] [Full Text] [Related]
3. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
Cohen J
Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
[No Abstract] [Full Text] [Related]
4. [Drugs for antiretroviral therapy. The costs of HAART].
Jablonowski H
MMW Fortschr Med; 2008 Apr; 150 Spec No 1():21. PubMed ID: 19024911
[No Abstract] [Full Text] [Related]
5. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
[No Abstract] [Full Text] [Related]
6. The future of generic HIV drugs in Rhode Island.
Lee JY; Reece R; Montague B; Rana A; Alexander-Scott N; Flanigan T
R I Med J (2013); 2013 Sep; 96(9):30-3. PubMed ID: 24015398
[TBL] [Abstract][Full Text] [Related]
7. Access to essential medications for HIV/AIDS in South Africa.
Andrews S
S Afr Med J; 2001 May; 91(5):384-7. PubMed ID: 11455797
[No Abstract] [Full Text] [Related]
8. Global AIDS trial denied patients as US balks at generic drug use.
Check E
Nature; 2004 Sep; 431(7008):493. PubMed ID: 15457219
[No Abstract] [Full Text] [Related]
9. [Therapy of hypertension. Cost conscious prevention of complications].
Kolloch RE
MMW Fortschr Med; 2003 Nov; 145(47):64. PubMed ID: 14725042
[No Abstract] [Full Text] [Related]
10. Indian company seeks US approval for generic AIDS drugs.
Nature; 2004 Aug; 430(7001):716. PubMed ID: 15306779
[No Abstract] [Full Text] [Related]
11. Hope for South Africa--at last.
Lancet; 2003 Aug; 362(9383):501. PubMed ID: 12932376
[No Abstract] [Full Text] [Related]
12. Stirring the statistical pot.
Bateman C
S Afr Med J; 2004 Mar; 94(3):154-5. PubMed ID: 15098266
[No Abstract] [Full Text] [Related]
13. Just the medicine. Cheaper AIDS drugs.
Whitelaw K
US News World Rep; 2001 Mar; 130(12):31. PubMed ID: 11277041
[No Abstract] [Full Text] [Related]
14. Drifting policies are wasting billions.
Suh GH
Int Psychogeriatr; 2012 Mar; 24(3):343-5. PubMed ID: 22078134
[No Abstract] [Full Text] [Related]
15. Public health. Global HIV/AIDS policy in transition.
Bongaarts J; Over M
Science; 2010 Jun; 328(5984):1359-60. PubMed ID: 20538936
[No Abstract] [Full Text] [Related]
16. [The patent legislation in India fails the HIV/AIDS work].
Holen Ø
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2666-7. PubMed ID: 16215618
[No Abstract] [Full Text] [Related]
17. [Health care too costly? Saving more than 10 million euros in 2 months!].
Rappert B
MMW Fortschr Med; 2003 Nov; 145(47):65. PubMed ID: 14725043
[No Abstract] [Full Text] [Related]
18. Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth?
Meiners C; Sagaon-Teyssier L; Hasenclever L; Moatti JP
PLoS One; 2011; 6(8):e23478. PubMed ID: 21858138
[TBL] [Abstract][Full Text] [Related]
19. [The treatment of AIDS too expensive?].
Kutschki I
Dtsch Med Wochenschr; 1998 Mar; 123(10):A12. PubMed ID: 9528643
[No Abstract] [Full Text] [Related]
20. The impact of visa status and Medicare eligibility on people diagnosed with HIV in Western Australia: a qualitative report.
Herrmann S; Wardrop J; John M; Gaudieri S; Lucas M; Mallal S; Nolan D
Sex Health; 2012 Nov; 9(5):407-13. PubMed ID: 22950904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]